Functional SRS for Tremor, Parkinson’s Disease & Dystonia Treatments: The CyberKnife® System utilizing Brainlab® Elements software

Accuray October 27, 2026

Title: Functional SRS for Tremor, Parkinson’s Disease & Dystonia Treatments: The CyberKnife® System utilizing Brainlab® Elements software

Date: October 27th, 2026

Time: 8:30am EDT | 2:30pm CEST | 8:30pm HKT 

Presenter 1: Pantaleo Romanelli, MD

Founder & Director of Neurosurgery and Stereotactic Radiosurgery, The Renaissance Institute, USA

Presenter 2: Jun Yang, PhD, DABR

Chief Scientist, Janusyn Oncology Group (USA) | Expert in scientific and clinical collaboration between the United States and China

Description: 

This educational webinar will bring together the combined expertise of Dr. Pantaleo Romanelli and Dr. Jun Yang, representing nearly 50 years of collective experience in stereotactic radiosurgery, functional neurosurgery, and advanced treatment planning. Through their extensive clinical and technical backgrounds, participants will gain valuable insights into the evolving role of the CyberKnife® System and Brainlab® Elements software in the treatment of functional disorders such as tremor, Parkinson’s disease, and dystonia.

This webinar has applied to CAMPEP for approval of 1 Medical Physics Continuing Education Credit (MPCEC), ASRT for 1 Category A Continuing Education credit, 1 CPE Point for Singapore Society of Radiographers & 1 CPD Credit for Hong Kong Radiographers Board.

Learning Objectives:

  1. Differentiate stereotactic radiosurgery (SRS) treatment approaches for functional disorders, including tremor, Parkinson’s disease, and dystonia, utilizing the CyberKnife® System and Brainlab® Elements software.
  2. Critically evaluate the application of tractography and target delineation techniques within Brainlab Elements software to support accurate treatment planning for functional SRS procedures on the CyberKnife System.
  3. Review and interpret clinical cases and treatment outcomes to assess the role of functional SRS in the management of tremor, Parkinson’s disease, and dystonia.
DISCLAIMER: The statements and articles in the corporate news forum do not necessarily reflect the views of, and are not endorsed by ISRS. Please consult the specific corporate entity for relevant disclosures and restrictions related to these news features.